Elanco Animal Health Incorporated
Elanco Animal Health Incorporated (ELAN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ELAN · as of Sep 30, 2025
Ownership Breakdown
427
Institutional Holders
▲ 44 vs Q2
$11.50B
Total Inst. Value
▲ $3.81B vs Q2
499.45M
Shares Outstanding
freeFloat 99.08%
571.09M
13F Shares Held
▲ 32.54M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ELAN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
DODGE & COX pharmaceutical preparations | 82.76M | 16.67% | 16.67% | $1.67T | Nov 13, 2025 | ▼ 135.4K |
FMR LLC pharmaceutical preparations | 65.36M | 13.16% | 13.16% | $1.32T | Nov 13, 2025 | ▲ 474.0K |
PRIMECAP MANAGEMENT CO/CA/ pharmaceutical preparations | 49.96M | 10.06% | 10.06% | $1.01T | Nov 12, 2025 | ▼ 1.81M |
VANGUARD GROUP INC pharmaceutical preparations | 48.59M | 9.78% | 9.78% | $978.54B | Nov 7, 2025 | ▲ 759.6K |
BLACKROCK, INC. pharmaceutical preparations | 46.18M | 9.30% | 9.30% | $930.04B | Nov 12, 2025 | ▲ 23.11M |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. pharmaceutical preparations | 31.51M | 6.35% | 6.35% | $634.61B | Nov 14, 2025 | ▲ 11.96M |
DIMENSIONAL FUND ADVISORS LP pharmaceutical preparations | 24.71M | 4.98% | 4.98% | $497.61B | Nov 12, 2025 | ▲ 1.96M |
UBS GROUP AG pharmaceutical preparations | 16.47M | 3.32% | 3.32% | $331.67B | Nov 13, 2025 | ▲ 5.96M |
STATE STREET CORP pharmaceutical preparations | 15.25M | 3.07% | 3.07% | $307.05B | Nov 14, 2025 | ▲ 6.12M |
BLACK CREEK INVESTMENT MANAGEMENT INC. pharmaceutical preparations | 12.48M | 2.51% | 2.51% | $251.40B | Nov 12, 2025 | ▼ 6.77M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
28
Increased
+67.90M shares1
New Positions
first time holders21
Decreased
−33.80M shares0
Sold Out
fully exitedNet shares change (top 50)
+34.09M
+67.90M / −33.80M
Net new holders
+8
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ELAN insider trading · insider activity
Source: SEC Form 4
54
Buy transactions
20
Sell transactions
2.70
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
VanHimbergen Robert M EVP and CFO | May 29, 2026 | Award | 8.261 | — | — | 92.681 | Form 4 ↗ |
Modi Rajeev A. SEE REMARKS | May 29, 2026 | Award | 61.926 | — | — | 9.4K | Form 4 ↗ |
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR | May 29, 2026 | Award | 118.53 | — | — | 24.4K | Form 4 ↗ |
Scots-Knight Denise director | May 21, 2026 | Award | 12,196 | — | — | 105.6K | Form 4 ↗ |
Scots-Knight Denise director | May 21, 2026 | Award | 4,678 | — | — | 93.4K | Form 4 ↗ |
Kurzius Lawrence Erik director | May 21, 2026 | Award | 12,196 | — | — | 148.6K | Form 4 ↗ |
Kurzius Lawrence Erik director | May 21, 2026 | Award | 4,678 | — | — | 136.5K | Form 4 ↗ |
McDonald Kirk P director | May 21, 2026 | Award | 12,196 | — | — | 105.6K | Form 4 ↗ |
McDonald Kirk P director | May 21, 2026 | Award | 4,678 | — | — | 93.4K | Form 4 ↗ |
Herendeen Paul director | May 21, 2026 | Award | 12,196 | — | — | 101.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Elanco Animal Health Incorporated (ELAN) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 0.92%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Elanco Animal Health Incorporated is DODGE & COX, holding approximately 82.76 million shares — equal to 16.67% of outstanding shares — as of September 30, 2025.
A total of 427 institutional investors currently hold ELAN stock, with a combined institutional value of approximately $11.50 billion as of the most recent 13F filing period.
Frequently asked questions
ELAN ownershipElanco Animal Health Incorporated (ELAN) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is DODGE & COX with a 16.67% stake. Company insiders hold 0.92%. Data sourced from SEC Form 13F as of September 30, 2025.